BRAF and melanoma: 3.4. Neither the Decrease in RIPK4 Using siRNA nor Crisp/Cas9-Mediated Overexpression of RIPK4 Affects PEBP1 or BRAF/ERK/MEK Signaling Pathway in Melanoma Cell Lines